This article was first published by The Times of Israel and is re-posted with permission.
Clinical trials for a new stem cell treatment have “frozen” the progression of multiple sclerosis, and left some patients in better condition than before they were injected, even ditching walking sticks, according to Jerusalem doctors.
The biopharmaceutical company NeuroGenesis has licensed a method developed at Hadassah Medical Center to take stem cells from MS patients’ own bone marrow.
“We inject it, and it rebuilds the external lining of the nerves, the myelin, that is affected by multiple sclerosis,” Dimitrios Karussis, head of Hadassah’s MS department and one of the neurologists behind the innovation, told The Times of Israel.
To read the full article, click here.
- BrainStorm Gets FDA Approval For New Experimental Drug To Treat Progressive MS
- Israeli Neuroscientist’s New Alzheimer’s Treatment To Head For Clinical Trial